Pharmacovigilance & Safety

HOME – Pharmacovigilance & Safety

Pharmacovigilance and Patient Safety

Lumina Health Sciences places patient safety and product integrity at the core of its operations through a comprehensive pharmacovigilance framework aligned with local regulations and global best practices. Our approach includes continuous safety monitoring across the product lifecycle, structured adverse event reporting, proactive risk management, and close coordination with regulatory authorities and manufacturing partners. This integrated system ensures timely risk identification, regulatory compliance, and ongoing protection of patient well-being while maintaining the highest standards of safety and quality.

Patient Safety Cornerstone

Patient safety is a cornerstone of Lumina’s operations, underpinned by a structured pharmacovigilance system meticulously aligned with both local regulatory requirements and global best practices.

Continuous Safety Monitoring

Systematic monitoring of product safety data to identify potential risks and ensure ongoing safety evaluation throughout the product lifecycle.

Adverse Event Reporting

Thorough documentation and reporting of adverse events in compliance with regulatory requirements, ensuring prompt investigation and appropriate follow-up.

Proactive Risk Management

Implementation of proactive risk minimization strategies, including risk evaluation, mitigation, and communication to ensure product safety.

Regulatory Coordination

Close coordination with regulatory authorities and manufacturing partners to ensure compliance with all applicable regulations and guidelines.

Partnering for Better Patient Outcomes

From retina injectables to specialty biosimilars, Lumina delivers advanced pharmaceutical solutions with commitment, care, and scientific precision—ensuring patients receive the right treatment at the right time.